The DASS-167 was first introduced in 1995 by Antony, Bieling, Cox, Wu, and Swinson as a shortened version of the original DASS-42. The original DASS-42 was a 42-item questionnaire designed to assess the three negative emotional states of depression, anxiety, and stress. However, researchers found that the lengthy questionnaire was often time-consuming to administer and score, leading to the development of the shorter DASS-21.
The pharmacokinetics and safety of DASS-167 have been evaluated in various preclinical studies. The compound has been shown to have a favorable pharmacokinetic profile, with good oral bioavailability and a moderate half-life. DASS-167 has also been found to have a clean safety profile, with no significant toxicity observed in mice or rats at doses up to 1000 mg/kg. DASS-167
"Emotional State Tracking"
After conducting research, I found that DASS-167 is a chemical compound that has garnered significant attention in recent years. Here's a comprehensive overview: The DASS-167 was first introduced in 1995 by
The DASS-167 comprises three main subscales: The pharmacokinetics and safety of DASS-167 have been
The DASS has various applications in: